The initial phase of clinical proteomics focuses heavily on biomarker discovery, a process that has evolved from serendipitous observation to high-throughput, systematic screening. In the context of ...

Evosep, a leading provider of sample preparation solutions for mass spectrometry-based proteomics, today announced a co-marketing agreement with Thermo Fisher Scientific, a world leader in serving ...

Courtesy of Bruker Daltonics Bruker Daltonics of Billerica, Mass., has developed a new mass spectrometry system that the company describes as a "holistic solution" for clinical proteomics and ...

Proteomics has become an essential area in medical research, propelled by the ability to quantitatively assess proteins on a large scale using high-throughput technologies. These technologies have ...

This article explores how biobanks, proteomics, and AI are enabling population-scale insights, earlier disease detection, and ...

Rethinking Clinical Proteomics For a while it looked as if proteomics' next frontier was the clinic, if one was to believe the hype surrounding a 2002 study from US Food and Drug Administration ...

Protein biomarker discovery, validation and utilization require technologies that deliver proteome insights with breadth and depth. Liquid chromatography mass spectrometry (LC-MS), the gold-standard ...

n this study, 773 untreated breast cancer patients from all over China were collected and followed up for at least 5 years. We obtained clinical data from 773 cases, RNA sequencing data from 752 cases ...

In mass spectrometry (MS), workflows are being streamlined and analyses are becoming more sophisticated. In short, MS is becoming faster, easier to use, and more functional. This is welcome news for ...